Synovasure® Alpha Defensin Test

Product Description

Synovasure® Alpha Defensin Test

Introducing Synovasure Alpha Defensin Test for Joint Infection


The Synovasure Alpha Defensin Test is the first and only test specifically designed and validated for the diagnosis of Joint Infection.  Developed to deliver accuracy, performance and ease of use.

Unparalleled Accuracy

  • The Synovasure Test achieves 97% sensitivity and 96% specificity by measuring synovial fluid alpha defensin1
  • Alpha defensin is an antimicrobial peptide released by neutrophils in response to pathogens
  • Alpha defensin is an ideal biomarker for PJI due to the tremendous separation it achieves between positives and negatives1

Performance backed by data

In the 149 patient study1, the Synovasure Alpha Defensin Test maintained its performance in typically challenging situations such as:

  • Culture Negative Infection

14 of 38 patients with PJI were culture negative and the Synovasure Alpha Defensin Test correctly identified all 14 as infected

  • Systemic Inflammatory Conditions

Synovasure Alpha Defensin Test studies included patients with systemic inflammatory disease and its performance was maintained in this population

  • Antibiotic Therapy

27% of patients with PJI had been treated with antibiotics prior to aspiration and the Synovasure Alpha Defensin Test was not adversely affected in this population.


    Surgitech Logo 251x69

    SURGI-TECH Egypt is a leading company in the medical field in Middle East established 1990 in Egypt. we treasure dedication and moved to satisfy customers, accepting nothing less than loyalty and are committed to the highest standards of ethics and integrity and to assure the quality of the products.

    ©SurgiTech Company 2021. All rights reserved. Created by Webbingstone